FILE PHOTO: A health worker receives a dose of the Pfizer-BioNTech COVID-19 vaccine in Madrid, Spain, February 4, 2021. REUTERS/Sergio Perez
(Reuters) - The EU's drug regulator on Thursday approved the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of five and 11, opening the way for them to be given a first shot as Europe battles surging infections.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Josephine Mason and Alexander Smith)
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
